234 related articles for article (PubMed ID: 12640682)
1. Analysis of chromosomal instability in pulmonary or liver metastases and matched primary hepatocellular carcinoma after orthotopic liver transplantation.
Gross-Goupil M; Riou P; Emile JF; Saffroy R; Azoulay D; Lacherade I; Receveur A; Piatier-Tonneau D; Castaing D; Debuire B; Lemoine A
Int J Cancer; 2003 May; 104(6):745-51. PubMed ID: 12640682
[TBL] [Abstract][Full Text] [Related]
2. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite instability and p53 mutations in hepatocellular carcinoma.
Karachristos A; Liloglou T; Field JK; Deligiorgi E; Kouskouni E; Spandidos DA
Mol Cell Biol Res Commun; 1999; 2(3):155-61. PubMed ID: 10662591
[TBL] [Abstract][Full Text] [Related]
4. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
[TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
Cazals-Hatem D; Rebouissou S; Bioulac-Sage P; Bluteau O; Blanché H; Franco D; Monges G; Belghiti J; Sa Cunha A; Laurent-Puig P; Degott C; Zucman-Rossi J
J Hepatol; 2004 Aug; 41(2):292-8. PubMed ID: 15288479
[TBL] [Abstract][Full Text] [Related]
6. The association of frequent allelic loss on 17p13.1 with early metastatic recurrence of hepatocellular carcinoma after liver transplantation.
Zhou L; Zhou W; Wu L; Yu X; Xing C; Zheng S
J Surg Oncol; 2010 Dec; 102(7):802-8. PubMed ID: 20886556
[TBL] [Abstract][Full Text] [Related]
7. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
8. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.
Edamoto Y; Hara A; Biernat W; Terracciano L; Cathomas G; Riehle HM; Matsuda M; Fujii H; Scoazec JY; Ohgaki H
Int J Cancer; 2003 Sep; 106(3):334-41. PubMed ID: 12845670
[TBL] [Abstract][Full Text] [Related]
9. [Molecular mechanism of hepatocarcinogenesis].
Imazeki F; Saisho H
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2154-61. PubMed ID: 10635298
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
[TBL] [Abstract][Full Text] [Related]
12. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
[TBL] [Abstract][Full Text] [Related]
13. Genetics of hepatocellular carcinoma.
Buendia MA
Semin Cancer Biol; 2000 Jun; 10(3):185-200. PubMed ID: 10936068
[TBL] [Abstract][Full Text] [Related]
14. Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors.
Wu Y; Renard CA; Apiou F; Huerre M; Tiollais P; Dutrillaux B; Buendia MA
Oncogene; 2002 Feb; 21(10):1518-26. PubMed ID: 11896580
[TBL] [Abstract][Full Text] [Related]
15. Investigation in liver tissues and cell lines of the transcription of 13 genes mapping to the 16q24 region that are frequently deleted in hepatocellular carcinoma.
Riou P; Saffroy R; Comoy J; Gross-Goupil M; Thiéry JP; Emile JF; Azoulay D; Piatier-Tonneau D; Lemoine A; Debuire B
Clin Cancer Res; 2002 Oct; 8(10):3178-86. PubMed ID: 12374686
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.
Buendia MA
Med Pediatr Oncol; 2002 Nov; 39(5):530-5. PubMed ID: 12228912
[TBL] [Abstract][Full Text] [Related]
17. [Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma].
Pang JZ; Qin LX; Ren N; Ye QH; Ying WD; Liu YK; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1662-5. PubMed ID: 16854315
[TBL] [Abstract][Full Text] [Related]
18. [Genome-wide loss of heterozygosity analyses in primary hepatocellular carcinoma].
Li S; Wang H; Zhang C
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):577-81. PubMed ID: 11798820
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1.
Chen Ban K; Singh H; Krishnan R; Fong Seow H
J Surg Oncol; 2004 Jun; 86(3):157-63. PubMed ID: 15170655
[TBL] [Abstract][Full Text] [Related]
20. Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis.
Yuan RH; Jeng YM; Chen HL; Hsieh FJ; Yang CY; Lee PH; Hsu HC
Clin Cancer Res; 2005 Apr; 11(7):2568-75. PubMed ID: 15814635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]